HOSPITALIZATION AND EXACERBATION ESTIMATES OF EFGARTIGIMOD VS. CONVENTIONAL THERAPY IN GENERALIZED MYASTHENIA GRAVIS PATIENTS: A POST-HOC ANALYSIS OF THE PHASE 3 ADAPT STUDY

被引：0
|
作者：
Qi, C. [1 ]
Dewilde, S. [2 ]
Gelinas, D. [1 ]
Brauer, E. [1 ]
Phillips, G. [1 ]
机构：
[1] Argenx Inc, Boston, MA USA
[2] SHE, Brussels, Vbr, Belgium
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO135
引用
收藏
页码：S329 / S329
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
    Hibi, Toshifumi
    Motoya, Satoshi
    Hisamatsu, Tadakazu
    Hirai, Fumihito
    Watanabe, Kenji
    Matsuoka, Katsuyoshi
    Saruta, Masayuki
    Kobayashi, Taku
    Feagan, Brian G.
    Tasset, Chantal
    Besuyen, Robin
    Yun, Chohee
    Crans, Gerald
    Zhang, Jie
    Kondo, Akira
    Watanabe, Mamoru
    INTESTINAL RESEARCH, 2022, : 110 - 125
  • [42] Early disease efficacy of guselkumab therapy in biologic-naive patients with moderately to severely active Crohn's disease: Post-hoc analysis from the phase 3 GALAXI 2 & 3 studies
    Afzali, A.
    Rubin, D. T.
    Danese, S.
    Rayyan, Y.
    Chen, M.
    Terry, N. A.
    Salese, L.
    Van Rampelbergh, R.
    Yee, J.
    Gomez, M.
    Wan, K. Y. Y.
    Yang, Z.
    Sands, B. E.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i200 - i201
  • [43] Efficacy of Guselkumab in Bionaive Psoriatic Arthritis Patients with Severe Disease Activity: Post-hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
    Ritchlin, Christopher
    Lubrano, Ennio
    Chimenti, Maria Sole
    Leibowitz, Evan
    Sharaf, Mohamed
    Adelakun, Oyediran
    Rampakakis, Emmanouil
    Nantel, Francois
    Lavie, Frederic
    Deodhar, Atul
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2999 - 3001
  • [44] Dynamic Changes in and Predictive Value of Lymphocytes in Patients with Breast Cancer Receiving Hypofractionated vs. Conventional Fractionated Radiotherapy after Breast Conserving Surgery: A Post Hoc Analysis of a Phase III Randomized Trial
    Song, Y.
    Chen, S.
    Zhao, X.
    Jing, H.
    Fang, H.
    Tang, Y.
    Hu, S.
    Song, Y.
    Jin, J.
    Liu, Y.
    Qi, S.
    Sun, G.
    Zhong, Q.
    Du, X.
    Liu, J.
    Li, Y.
    Wang, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S200 - S200
  • [45] Efficacy of novel β3-adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post-hoc analysis of a randomized, double-blind, placebo-controlled phase 3 study
    Yoshida, Masaki
    Takeda, Masayuki
    Gotoh, Momokazu
    Yokoyama, Osamu
    Kakizaki, Hidehiro
    Takahashi, Satoru
    Masumori, Naoya
    Nagai, Shinji
    Hashimoto, Keita
    Minemura, Kazuyoshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (03) : 369 - 375
  • [46] Impact of Galcanezumab on Total Pain Burden in Patients With Chronic Cluster Headache: Post-hoc Analysis From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
    Kudrow, D.
    Kuruppu, D.
    Andrews, J.
    Rettiganti, M.
    Oakes, T. M.
    Bardos, J.
    Wenzel, R.
    Gaul, C.
    Martinez, J.
    Lipton, R. B.
    HEADACHE, 2020, 60 : 108 - 109
  • [47] Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8-week, multicenter, double-blind, randomized controlled study
    Harvey, Philip D.
    Nakamura, Hiroshi
    Miura, Sadanori
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (01) : 63 - 72
  • [48] Rapidity of symptom improvements during filgotinib induction therapy in patients with Ulcerative Colitis: Post hoc analysis of the phase 2b/3 SELECTION study
    Danese, S.
    Hibi, T.
    Ritter, T. E.
    Dinoso, J. B.
    Hsieh, J.
    Yun, C.
    Zhang, J.
    Zhao, S.
    Loftus, E. V., Jr.
    Rogler, G.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S034 - S035
  • [49] Cardiovascular safety of vibegron, a new β3-adrenoceptor agonist, in older patients with overactive bladder: Post-hoc analysis of a randomized, placebo-controlled, double-blind comparative phase 3 study
    Yoshida, Masaki
    Takeda, Masayuki
    Gotoh, Momokazu
    Yokoyama, Osamu
    Kakizaki, Hidehiro
    Takahashi, Satoru
    Masumori, Naoya
    Nagai, Shinji
    Minemura, Kazuyoshi
    NEUROUROLOGY AND URODYNAMICS, 2021, 40 (06) : 1651 - 1660
  • [50] Editorial Comment to Efficacy of novel β3-adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post-hoc analysis of a randomized, double-blind, placebo-controlled phase 3 study
    Kitta, Takeya
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (03) : 375 - 376
12345